Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels

PURPOSE: T cells genetically modified to express chimeric antigen receptors (CARs) targeting CD19 (CAR-19) have potent activity against acute lymphoblastic leukemia, but fewer results supporting treatment of lymphoma with CAR-19 T cells have been published. Patients with lymphoma that is chemotherap...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Oncol
Main Authors: Kochenderfer, James N., Somerville, Robert P.T., Lu, Tangying, Shi, Victoria, Bot, Adrian, Rossi, John, Xue, Allen, Goff, Stephanie L., Yang, James C., Sherry, Richard M., Klebanoff, Christopher A., Kammula, Udai S., Sherman, Marika, Perez, Arianne, Yuan, Constance M., Feldman, Tatyana, Friedberg, Jonathan W., Roschewski, Mark J., Feldman, Steven A., McIntyre, Lori, Toomey, Mary Ann, Rosenberg, Steven A.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2017
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455597/
https://ncbi.nlm.nih.gov/pubmed/28291388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.3024
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki